Dr. Michael J. Klebuc, MD

Dr. Klebuc practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Klebuc's NPI, 1225067887, was assigned on July 3, 2006. Dr. Klebuc graduated from University Saskatchewan Royal Hospital in 1993. Dr. Klebuc holds Texas license L0341.

Dr. Klebuc's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Klebuc's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. The medical group on file is Houston Methodist Institute for Reconstructive Surgery. Dmand AI also links Dr. Klebuc to 1 more group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klebuc practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Klebuc's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Klebuc is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Klebuc is licensed in Texas.

CMS data shows 25 Medicare services from Dr. Klebuc across 1 procedure code in 2024, all of them office visits, for 32 Medicare patients. Medicare paid $1,652 for them. Every service was in an office.

CMS counts 32 Medicare patients who saw Dr. Klebuc in 2024. The largest group is 65 to 74, with 20 patients. 63% of them have high blood pressure, and 59% have high cholesterol. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Klebuc's median patient age at 57, with 57% women.

In 2024, Dr. Klebuc wrote 22 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $73 in total drug cost. In 2022, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Klebuc for performance year 2024, reported as part of a group. Dr. Klebuc accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Klebuc, published from 2008 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Surgical Flaps, Plastic Surgery Procedures and Bone Transplantation. Dr. Klebuc has published most often in Plast Reconstr Surg. Dr. Klebuc's most frequent co-authors are Peirong Yu, MD, Matthew Mitsuru Hanasono, MD and Larry H. Hollier, MD.

Dmand AI links Dr. Klebuc to 1 clinical trial. Conditions studied include Facial Paralysis and Paralysis.

CMS Open Payments shows 74 general payments to Dr. Klebuc from 20 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 98% of the total. Baxter Healthcare paid the most, $200,036.

Dmand AI lists 3 awards for Dr. Klebuc, most recently Top Doctors:SE Texas in 2013.

Dr. Klebuc graduated from University Saskatchewan Royal Hospital in 1993. Dr. Klebuc is a member of ASPS.

Dr. Klebuc is in network with 10 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.